Anaplasma marginale inactivated vaccine: Dose titration against a homologous challenge

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 23, Issue 4, 2000, Pages 239-252

  Rodriguez S D ^a   Garcia Ortiz M A ^a,b   Hernandez Salgado G ^a   Santos Cerda, N A ^c   Aboytes Torres, R ^a   Canto Alarcon G J ^a,c  

^a INSTITUTO NACIONAL DE INVESTIGACIONES FORESTALES   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

Author keywords

Anaplasma marginale; Bovines; Dose titration; Homologous challenge; Inactivated vaccine; Initial bodies

Indexed keywords

ADJUVANT; ANAPLASMOSIS VACCINE; ANTIGEN; INACTIVATED VACCINE;

ANAPLASMA; ANAPLASMA MARGINALE; ANAPLASMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; CATTLE; CONTROLLED STUDY; COW; DEATH; ERYTHROCYTE; GEOGRAPHIC DISTRIBUTION; HEMATOCRIT; IMMUNOGENICITY; INOCULATION; MEXICO; NONHUMAN; PROTECTION; PURIFICATION; TITRIMETRY; VACCINATION; WEIGHT REDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANAPLASMA; ANAPLASMOSIS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BODY TEMPERATURE; BODY WEIGHT; CATTLE; CATTLE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOCRIT; MEXICO; RANDOM ALLOCATION; VACCINATION; VACCINES, INACTIVATED;

ANAPLASMA MARGINALE; ANIMALIA; BOS TAURUS; BOVINAE; RICKETTSIALES;

EID: 0033826471     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9571(99)00076-4     Document Type: Article

References (41)

1. Anaplasmosis bovina, con enfasis en control, diagnostico, distribucion de la enfermedad en Mexico y uso de la vacuna atenuada de A. marginale
2. Bovine leucosis virus contamination of a vaccine produced in vivo against bovine babesiosis and anaplasmosis
3. Comparison of three methods of immunization against bovine anaplasmosis: An examination of postvaccinal effects
4. Effects and use of a modified live Anaplasma marginale vaccine in beef heifers in California
5. Sheep-adapted Anaplasma marginale maintains virulence for cattle
6. Study of an attenuated Anaplasma marginale vaccine in Mexico-Natural challenge of immunity in enzootic area
7. Ensayo de una vacuna experimental inactivada contra Anaplasma marginale
8. Comparison of three methods of immunization against bovine anaplasmosis: Evaluation of protection afforded against field challenge exposure
9. Comparative efficacy of different immunization systems against anaplasmosis
10. Vaccination with Anaplasma centrale: Response after an experimental challenge with Anaplasma marginale
11. Vaccines against hemoparasitic diseases in Israel with special reference to quality assurance
12. Frozen Anaplasma centrale vaccine against anaplasmosis in cattle
13. Comparative response of Frisian milking cows and calves to Anaplasma centrale vaccine
14. Infectivity, virulence and immunogenicity of Anaplasma centrale live blood vaccine. Onderstepoort
15. Analisis de la situacion de las vacunas contra anaplasmosis y babesiosis. Conclusiones y recomendaciones presentadas por el Comite de enfermedades parasitarias
16. Progress toward an improved vaccine for anaplasmosis
17. Field studies of an experimental anaplasmosis vaccine on pregnant cows and neonatal isoerythrolysis
18. Efficacy of purified Anaplasma marginale initial bodies as vaccine against anaplasmosis
19. Anaplasma vaccines
20. Immunization of cattle with the MSP-1 surface protein complex induces protection against a structurally variant Anaplasma marginale isolate
21. Immunization with an isolate-common surface protein protects cattle against anaplasmosis
22. Immunization of cattle with a 36-kilodalton surface protein induces protection against homologous and heterologous Anaplasma marginale challenge
23. Crossprotective immunity between the Florida and a Zimbabwe stock of Anaplasma marginale
24. Common and isolate-restricted antigens of Anaplasma marginale detected with monoclonal antibodies
25. Molecular size variations in an immunoprotective complex among isolates of Anaplasma marginale
26. Recognition of conserved surface protein epitopes on Anaplasma marginale isolates from Israel, Kenya and the United States
27. Neonatal immunohemolytic anemia and icterus of calves
28. Experiencias sobre el uso de vacunas contra Anaplasma marginale, Memoria de la IV Reunion Anual
29. Caracterizacion de la virulencia de un aislado mexicano de Anaplasma marginale
30. Immune serum against Anaplasma marginale initial bodies neutralizes infectivity for cattle
31. Preparation and characterization of a soluble Anaplasma marginale antigen
32. Detection of antibodies to Anaplasma marginale by an improved enzyme-linked immunosorbent assay with sodium dodecyl sulfate-disrupted antigen
33. Attempts at immunizing cattle against anaplasmosis using killed vaccine
34. Bovine type 1 and type 2 responses
35. Palmer G.H. CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge
36. Functional properties of bovine IgG1 and IgG2: Interactions with complement, macrophages, neutrophils and skin
37. Finite purification of Anaplasma marginale: Serologic inactivity of the anaplasma body
38. Serologic and clinical responses of premunized, vaccinated, and previously infected cattle to challenge exposure by two different Anaplasma marginale isolates
39. Efficacy of attenuated Anaplasma marginale vaccine under laboratory and field conditions in Colombia
40. The repertoire of Anaplasma marginale antigens recognized by CD4(+) T-lymphocyte clones from protectively immunized cattle is diverse and includes major surface protein 2 (MSP-2) and MSP-3